Genetics, gender, and even botched timing on the part of the immune response all appear important in the development of COVID-19. Akiko Iwasaki, PhD, is leading research to help us better predict who is likely to sail through a bout with COVID-19 and who may need targeted lifesaving care.
- January 14, 2021Source: YaleNews
In a paper published Jan. 14 in the journal Cell, four Yale immunobiologists propose an expanded explanation for the rise of food allergies.
- January 12, 2021
Carrie Lucas, PhD and Aaron Ring, MD, PhD are winners of two 2020 International Cytokine & Interferon Society Young Investigator AwardsSource: The International Cytokine & Interferon Society (ICIS)
Carrie Lucas, PhD and Aaron Ring, MD, PhD are winners of two 2020 International Cytokine & Interferon Society Young Investigator Awards—the Christina Fleischmann Award to Young Women Investigators and the Milstein Young Investigator Award, respectively.
- January 11, 2021Source: WNPR
Dr. Ellen Foxman speaks on Connecticut Public Radio on the COVID 19 vaccine rollout
- December 17, 2020
Discoveries & Impact (December 2020)
- December 17, 2020
This is one example of NHP’s important role providing free blood pressure and blood sugar screenings in the New Haven community. Yale medical, physician associate (PA), nursing, and public health students volunteer at the NHP, while a rotating set of 30 faculty serve as attendings.
- December 13, 2020Source: The Guardian
Scientists find aberrant immune system in patients with virus could also be cause of ‘long Covid’
- November 11, 2020Source: YaleNews
Yale researchers have discovered a protein that helps protect hosts from infection with the tick-borne spirochete that causes Lyme Disease, a finding that may help diagnose and treat this infection.
- October 30, 2020Source: Healthline
New Evidence That Coronavirus Antibodies Only Last a Few Months
- October 29, 2020Source: Science
“Having to adapt to different situations throughout my life prepared me [for] a different virus,” says Akiko Iwasaki of Yale University.